Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease

Background Noncompliance in use of anti-tumor necrosis factor (anti-TNF) therapy in patients with moderate-to-severe inflammatory bowel disease (IBD) can be a factor in medication failure. Few studies have evaluated the contribution of depressive symptoms to medication noncompliance in anti-TNF ther...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Digestive diseases and sciences 2017-12, Vol.62 (12), p.3563-3567
Hauptverfasser:	Calloway, Alexis, Dalal, Robin, Beaulieu, Dawn B., Duley, Caroline, Annis, Kimberly, Gaines, Lawrence, Slaughter, Chris, Schwartz, David A., Horst, Sara
Format:	Artikel
Sprache:	eng
Schlagworte:	Adalimumab Adult Aged Analysis Antibodies, Monoclonal - pharmacology Antibodies, Monoclonal - therapeutic use Biochemistry Colon Crohn's disease Depression - complications Depression, Mental Female Gastroenterology Hepatology Humans Inflammatory bowel disease Inflammatory Bowel Diseases - drug therapy Inflammatory Bowel Diseases - psychology Male Medication Adherence - psychology Medicine Medicine & Public Health Middle Aged Monoclonal antibodies Necrosis Oncology Original Article Patient compliance Patients Retrospective Studies Transplant Surgery Tumor necrosis factor Tumor Necrosis Factor-alpha - antagonists & inhibitors Tumor necrosis factor-TNF Tumors Ulcerative colitis Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!